Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/24/2025

Hemolysis Diagnosis and Management

Introduction to Hemolysis

  • The combination of low haptoglobin and elevated reticulocyte count strongly indicates active hemolysis, and should prompt immediate investigation to identify the underlying cause and assess clinical severity, as recommended by the American Gastroenterological Association 1, 2, 3

Diagnostic Approach

  • Elevated reticulocytes signal that the bone marrow is responding appropriately to anemia by increasing red blood cell production, which excludes nutritional deficiencies as the primary cause, according to the American Gastroenterological Association 1, 2, 4
  • Low haptoglobin occurs because this protein binds free hemoglobin released during red cell destruction and is then rapidly cleared from circulation, making it a sensitive marker of hemolysis, as noted by the American Gastroenterological Association 1, 2
  • The presence of hemolysis is confirmed when you see this combination alongside other markers: elevated lactate dehydrogenase (LDH), elevated unconjugated bilirubin, and the clinical picture, as recommended by the American Gastroenterological Association 1, 2

Differential Diagnosis

  • Hereditary conditions, such as pyruvate kinase deficiency, G6PD deficiency, hereditary spherocytosis, and sickle cell disease, can cause hemolysis, as reported by the American Society of Hematology 5
  • Non-immune causes, including thrombotic microangiopathies, mechanical destruction, and infections, can also lead to hemolysis, according to the American Society of Hematology 5

Management

  • Discontinuation of any potentially offending medications and assessment of the need for transfusion support are immediate considerations in the management of hemolysis, as recommended by the American Society of Hematology 5, 6
  • Monitoring for complications, such as iron overload in chronic hemolysis, thrombotic events, and gallstones, is crucial in the long-term management of hemolysis, as noted by the American Society of Hematology 5, 6
  • Serial hemoglobin, reticulocyte counts, and LDH, as well as iron studies and ferritin, are essential for assessing response to treatment and detecting potential complications, according to the American Society of Hematology 5, 6